Effects of batroxobin on the antithrombotic system in patients with cerebral venous thrombosis: Clues to mechanisms

Key Points

Key points are not available for this paper at this time.

Abstract

More evidence supports the benefits of batroxobin combined with anticoagulation in correcting acute cerebral venous thrombosis (CVT). The dynamic fluctuations of peripheral blood platelets, fibrinolysis, and coagulation biomarkers during this therapy were analyzed.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Lan et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5dfcbb6db643587573dc0 https://doi.org/https://doi.org/10.1111/cns.14861

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Platelets interact with fibrin only after activation1985 · 69 citations
2Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack2013 · 1,831 citations
3Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis2000 · 99 citations
4Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries1996 · 11 citations
5[Clinico-pharmacological observations of batroxobin (Defibrase) administered to normal human adults (author's transl)].1981 · 6 citations

Bookmark

View Full Paper